Prognosis and Targeted Therapy Related Molecular Screening Program for Patients of Breast Cancer in China
NCT03792529
·
clinicaltrials.gov ↗
UNKNOWN
Status
300
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
OTHER:
detect gene mutations of ctDNA and ctRNA
Sponsor
Peking University Cancer Hospital & Institute
Collaborators
[object Object]